1. Cholecystectomy in patients with hematologic malignancies
- Author
-
Yanghee Woo, Lily L. Lai, Thuy B. Tran, Yuman Fong, Andrew H Nguyen, Jasmine Zain, and Camille L. Stewart
- Subjects
Abdominal pain ,medicine.medical_specialty ,Blood transfusion ,medicine.medical_treatment ,Cholecystitis, Acute ,Postoperative Complications ,Cholecystitis ,medicine ,Humans ,Cholecystectomy ,In patient ,Single institution ,Retrospective Studies ,Gangrenous cholecystitis ,business.industry ,General Medicine ,Length of Stay ,medicine.disease ,Surgery ,Transplantation ,Treatment Outcome ,Cholecystectomy, Laparoscopic ,Hematologic Neoplasms ,Acute Disease ,medicine.symptom ,business - Abstract
Background Cholecystectomy in patients with hematologic malignancies remains poorly understood. Methods We retrospectively evaluated patients with hematologic malignancies who underwent cholecystectomy at a single institution. Results Of 313 patients who presented for evaluation of abdominal pain, 64 underwent cholecystectomy for acute cholecystitis (34.4%), gangrenous cholecystitis (21.9%), chronic cholecystitis (23.4%), and cholelithiasis (20%). Most had a history of hematopoietic cell transplantation (62.5%) and/or immunosuppressive medication within 30 days of consultation (82.8%). Ultrasound had a 39% false-negative rate for acute nongangrenous cholecystitis. Operative time was 92 ± 39 min, 7 were performed open, 10 had intraoperative transfusions, and 4 had grade 3+ complications. Intraoperative transfusion was associated with increased postoperative length of stay (p = 0.03). Open procedure, operative time, estimated blood loss, intraoperative transfusion, and complications were not associated with timing of surgery. Conclusions Patients with hematologic malignancies can safely undergo cholecystectomy. Length of postoperative stay for inpatients is associated with intraoperative blood transfusion.
- Published
- 2022